These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 23582920)
1. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours. Sundin A Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):803-18. PubMed ID: 23582920 [TBL] [Abstract][Full Text] [Related]
2. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumours: the role of imaging for diagnosis and therapy. van Essen M; Sundin A; Krenning EP; Kwekkeboom DJ Nat Rev Endocrinol; 2014 Feb; 10(2):102-14. PubMed ID: 24322649 [TBL] [Abstract][Full Text] [Related]
4. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors]. Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263 [TBL] [Abstract][Full Text] [Related]
5. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Zimmer T; Ziegler K; Bäder M; Fett U; Hamm B; Riecken EO; Wiedenmann B Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983 [TBL] [Abstract][Full Text] [Related]
6. Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors. Toumpanakis C; Kim MK; Rinke A; Bergestuen DS; Thirlwell C; Khan MS; Salazar R; Oberg K Neuroendocrinology; 2014; 99(2):63-74. PubMed ID: 24458014 [TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET. Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064 [TBL] [Abstract][Full Text] [Related]
8. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours. Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114 [TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging. Baumann T; Rottenburger C; Nicolas G; Wild D Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843 [TBL] [Abstract][Full Text] [Related]
11. [The state of the art of imaging in gastroenteropancreatic neuroendocrine tumors]. Yao X; Wang F Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):51-5. PubMed ID: 27045241 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942 [TBL] [Abstract][Full Text] [Related]
13. Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Prasad V; Kulkarni H; Haugvik SP; Hommann M; Baum RP Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1659-68. PubMed ID: 21626438 [TBL] [Abstract][Full Text] [Related]
14. 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients. Pfeifer A; Knigge U; Binderup T; Mortensen J; Oturai P; Loft A; Berthelsen AK; Langer SW; Rasmussen P; Elema D; von Benzon E; Højgaard L; Kjaer A J Nucl Med; 2015 Jun; 56(6):847-54. PubMed ID: 25952736 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled somatostatin analogs for radionuclide imaging and therapy in patients with gastroenteropancreatic neuroendocrine tumors. Bal CS; Gupta SK; Zaknun JJ Trop Gastroenterol; 2010; 31(2):87-95. PubMed ID: 20862981 [TBL] [Abstract][Full Text] [Related]
16. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues. Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128 [TBL] [Abstract][Full Text] [Related]
17. Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors? Cuccurullo V; Faggiano A; Scialpi M; Cascini GL; Piunno A; Catalano O; Colao A; Mansi L Minerva Endocrinol; 2012 Dec; 37(4):367-77. PubMed ID: 23235192 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Buchmann I; Henze M; Engelbrecht S; Eisenhut M; Runz A; Schäfer M; Schilling T; Haufe S; Herrmann T; Haberkorn U Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1617-26. PubMed ID: 17520251 [TBL] [Abstract][Full Text] [Related]
19. Radiological Imaging: Computed Tomography, Magnetic Resonance Imaging and Ultrasonography. Sundin A; Wills M; Rockall A Front Horm Res; 2015; 44():58-72. PubMed ID: 26303704 [TBL] [Abstract][Full Text] [Related]
20. Nuclear imaging of neuroendocrine tumours. Sundin A; Garske U; Orlefors H Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):69-85. PubMed ID: 17382266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]